Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2024Journal of Alzheimer s Disease

Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment

View Full Paper
Ask AI
Bookmark
Share

Authors

BNBhargav Teja NallapuAlbert Einstein College of MedicineKPKellen K. PetersenWashington University in St. LouisRichard B. LiptonRichard B. LiptonAstraZeneca (United Kingdom)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nallapu et al. (2024) studied this question.

synapsesocial.com/papers/68e785c1b6db6435876f89a8https://doi.org/10.3233/jad-230620
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of machine learning model for diagnostic disease prediction based on laboratory tests2021 · 192 citations
  2. 2P2‐143: Method Comparison of AB(1‐42) Measured in Human Cerebrospinal Fluid Samples by Liquid Chromatography‐Tandem Mass Spectrometry, the Inno‐Bia ALZBIO3 Assay, and the Elecsys® B‐Amyloid(1‐42) Assay2016 · 19 citations
  3. 3Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations2021 · 279 citations
  4. 4Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy2021 · 101 citations
  5. 5Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes2021 · 263 citations